[患者安全发展和评估]
Max Geraedts1, Ruth Hecker2, Cordula Mühr3
1Institut für Gesundheitsversorgungsforschung und Klinische Epidemiologie, Fachbereich Medizin, Philipps-Universität Marburg, Karl-von-Frisch-Straße 4, 35043, Marburg, Deutschland. geraedts@uni-marburg.de.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|December 3, 2025
概括
患者安全 (PaSi) 涉及创造一个安全的护理环境和文化,而不仅仅是防止不良事件. 大多数患者安全事件 (PSI) 没有被发现,这突显了对其原因和预防的更多研究的需要.
科学领域:
- 医疗保健的质量和安全
- 医学社会学 医学社会学
背景情况:
- 患者安全 (PaSi) 是一个关键的医疗保健目标,包括安全的护理环境和安全文化.
- 德国的利益相关者正在积极努力通过各种举措来加强PaSi.
研究的目的:
- 评估目前在德国确定患者安全的方法.
- 发现了解和解决患者安全事件 (PSI) 的差距.
主要方法:
- 通过关键事件报告系统 (CIRS) 利用患者调查和自愿报告.
- 分析了医疗记录和例行数据.
- 采用经典的质量管理方法来确定安全护理的先决条件.
主要成果:
- 大多数患者安全事件 (PSI) 仍未被发现.
- 显著需要进一步研究PSI发病率和决定因素.
结论:
- 目前评估患者安全的方法不足以捕捉所有事件.
- 进一步的研究对于开发有效的干预措施和培养强大的患者安全文化至关重要.
相关概念视频
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Preclinical Development: Overview
5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Clinically Relevant Drug Product Specifications: Methods of Establishment
186
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
186
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K


